CPTx at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

CPTx brings 3 presentations to ESGCT 2026 in Hamburg. Its work centres on generating CAR T cells inside the body with single-stranded DNA carried by targeted lipid nanoparticles. The data span fibrotic and cancer models, including clearance of spread tumours, together with close characterisation of the loaded particles.

OrganizationESGCT 2026 Attendance
CPTx
Planegg, Germany
Biotech
Develops immune-quiet single-stranded DNA delivered by targeted lipid nanoparticles to generate CAR-T cells inside the body.
Poster
Wed Oct 28
1:30pm–3:30pm
ssDNA-tLNPs enable multiplex in vivo CAR-T engineering across fibrotic and oncologic disease models
Immunotherapy and CAR T cells
Poster
Thu Oct 29
2:00pm–4:00pm
Advanced characterization of ssDNA-loaded targeted lipid nanoparticles for in vivo CAR T cell therapy
Immunotherapy and CAR T cells
Talk
Fri Oct 30
12:30pm–1:00pm
Targeted immune-silent ssDNA-tLNP delivery enables in vivo CAR-T generation and eradication of disseminated tumors
SESSION 12d: Non-viral vectors/Nanotechnology and RNA therapeutics II
Vectors and delivery (AAV, lentiviral, LNP)Cell therapies and CAR-T

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from CPTx

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction